Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Boehringer Ingelheim
Express Scripts
Novartis
UBS
Cipla
Accenture
Federal Trade Commission
Chubb
Cerilliant

Generated: January 23, 2018

DrugPatentWatch Database Preview

CHLORPROPAMIDE Drug Profile

« Back to Dashboard

When do Chlorpropamide patents expire, and what generic alternatives are available?

Chlorpropamide is a drug marketed by Ani Pharms Inc, Aurolife Pharma Llc, Dava Pharms Inc, Halsey, Mylan, Par Pharm, Sandoz, Superpharm, Usl Pharma, Watson Labs, and Watson Labs Teva. and is included in thirty-one NDAs.

The generic ingredient in CHLORPROPAMIDE is chlorpropamide. There are eleven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the chlorpropamide profile page.
Drug patent expirations by year for CHLORPROPAMIDE
Pharmacology for CHLORPROPAMIDE
Ingredient-typeSulfonylurea Compounds
Drug ClassSulfonylurea
Medical Subject Heading (MeSH) Categories for CHLORPROPAMIDE

US Patents and Regulatory Information for CHLORPROPAMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs Teva CHLORPROPAMIDE chlorpropamide TABLET;ORAL 088826-001 Sep 26, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs CHLORPROPAMIDE chlorpropamide TABLET;ORAL 088608-001 Apr 12, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs CHLORPROPAMIDE chlorpropamide TABLET;ORAL 086866-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ani Pharms Inc CHLORPROPAMIDE chlorpropamide TABLET;ORAL 088768-001 Oct 11, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan CHLORPROPAMIDE chlorpropamide TABLET;ORAL 088549-002 Jun 1, 1984 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Superpharm CHLORPROPAMIDE chlorpropamide TABLET;ORAL 088695-001 Sep 17, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ani Pharms Inc CHLORPROPAMIDE chlorpropamide TABLET;ORAL 087353-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ani Pharms Inc CHLORPROPAMIDE chlorpropamide TABLET;ORAL 088918-001 Oct 16, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Aurolife Pharma Llc CHLORPROPAMIDE chlorpropamide TABLET;ORAL 088725-001 Aug 31, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Par Pharm CHLORPROPAMIDE chlorpropamide TABLET;ORAL 088175-001 Feb 27, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Chinese Patent Office
Teva
Covington
Queensland Health
Harvard Business School
McKesson
Merck
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot